A THREE DIMENSIONAL REVIEW ON HUMAN IGNORANCE REGARDING ANTIMICROBIAL RESISTANCE

Similar documents
Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

WORLD ANTIBIOTIC AWARENESS WEEK

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

Antimicrobial Resistance, yes we care! The European Joint Action

IFMSA Policy Proposal Antimicrobial Resistance

COMMISSION OF THE EUROPEAN COMMUNITIES

ANTIMICROBIAL RESISTANCE: GLOBAL BURDEN

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

Hosted by Dr. Benedetta Allegranzi, WHO Patient Safety Agency A Webber Training Teleclass

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

National Action Plan development support tools

2016/LSIF/FOR/003 Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated Infections Antimicrobial Resistance

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune

WHO's View on IVDs for Addressing AMR

ANTIMICROBIAL RESISTANCE THE AUSTRALIAN CONTEXT. Professor Brendan Murphy Australian Government Chief Medical Officer

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

The challenge of growing resistance

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Stratégie et action européennes

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials

Tackling the need for new antibacterial drugs

IFMSA Policy Proposal [Antimicrobial Resistance]

Antimicrobial Resistance Initiative

: "INFECTION CONTROL: WHAT'S COMING IN 2017?" LISA THOMAS RN-BC STATE TRAINING COORDINATOR OFFICE OF LONG TERM CARE

Summary of the latest data on antibiotic resistance in the European Union

Canada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017

Evaluation of EU strategy to combat AMR

Keeping Antibiotics Working: Nursing Leadership in Action

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

Australia s response to the threat of antimicrobial resistance

Council of the European Union Brussels, 13 June 2016 (OR. en)

Dr Marc Sprenger Director Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance

Jaipur Declaration on Antimicrobial Resistance

AMR situation in Europe: Strategy and vision

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

Regional Workshop on AMR in South East Asia Penang (Malaysia): March 2018

More than EUR 56 million raised to fund initiative to fight antibiotic resistance

ANTIMICROBIAL RESISTANCE AND NATIONAL ACTION PLAN FOR PRUDENT USE OF ANTIMICROBIALS Egypt, GOVS 2017

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

The role of FAO in AMR

EU Research on Antimicrobial drug resistance Anna Lönnroth Sjödén Unit Infectious Diseases, Directorate Health DG Research European Commission

Healthcare Facilities and Healthcare Professionals. Public

Epidemiology and Economics of Antibiotic Resistance

The European AMR Challenge - strategic views from the human perspective -

Antimicrobial resistance

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play

CHALLENGES AND COLLABORATION

MRSA Outbreak in Firefighters

COPING WITH ANTIMICROBIAL RESISTANCE

What bugs are keeping YOU up at night?

These life-saving drugs have been a boon to medical care and benefited hundreds of million patients around the globe.

Stratégies et actions au niveau européen et international: populations humaines

Global Status of Antimicrobial Resistance with a Focus on Nepal

A Conversation with Dr. Steve Solomon and Dr. Jean Patel on Antimicrobial Resistance June 18 th, 2013

Pfizer Position on Antimicrobial Resistance Management. Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017

The Philippine Action Plan to Combat Antibiotic Resistance: One Health Approach

Perspective on AnA Global timicrobial Resistance

Dr Liz Tayler Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

Draft ESVAC Vision and Strategy

Global Communication on AMR in Animal Health: Tripartite and OIE Efforts

Surveillance of AMR in PHE: a multidisciplinary,

Antimicrobial Resistance at human-animal interface in the Asia-Pacific Region

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

The trinity of infection management: United Kingdom coalition statement

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

WHO perspective on antimicrobial resistance

First-year experiences in implementing Thailand s National Strategic Plan on AMR

Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

Overview of Infection Control and Prevention

Impact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Control and monitoring of the use of antibiotics as a strategy against antimicrobials resistance

ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

ANTIBIOTIC STEWARDSHIP

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

DR. BASHIRU BOI KIKIMOTO

Antibiotic Resistance A Major Threat to the Sustainable Development Goals

EU strategy to fight against Antimicrobial Resistance

Antimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson

Future Directions: Public Health The example of antimicrobial resistance

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

Antimicrobial Stewardship: The South African Perspective

USA ACTION PLAN FOR COMBATING ANTIBIOTIC-RESISTANT BACTERIA

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

Transcription:

A THREE DIMENSIONAL REVIEW ON HUMAN IGNORANCE REGARDING ANTIMICROBIAL RESISTANCE Abstract: Antimicrobial resistance is one of the biggest threats to global health, food security and development today. Antimicrobial resistance can affect anyone, of any age, in any country. Antimicrobial resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. A growing number of infections-such as tuberculosis, gonorrhea, and salmonellosis-are becoming harder to treat as the antibiotics used to treat them become less effective. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality. Keywords: antimicrobial resistance, chromosomal changes, vaccines, diagnostics sector. Contributors: 1. Dr. B. Karthika, MDS 2. Dr. T. Sridhar, MDS 3. Dr. M. Pavani, MDS 4. Dr. Naina Sam, BDS Department and Institution: Department of Oral Medicine and Radiology, Priyadarshini Dental College and Hospital, Thiruvallur City, Tamil Nadu Corresponding Author: Dr. M.Pavani, MDS International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 16

INTRODUCTION This article is mainly based on the human`s antimicrobial resistance in three different point of angles, Including private sector, public sector and by the world sector. Private sector by common individuals and its scope. [1] Public sector by professionals, agriculture, industry. World sector by World Health Organization (WHO), The Global Antibiotic Resistance Surveillance and System (GLASS), Global Antibiotic Research and Development Program(GADCP), International Coordination Group on Antimicrobial Resistance (IACG). [1] Antimicrobials are medicine used to prevent and treat bacterial infections. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Bacteria, not humans or animals, become antibiotic resistant. These bacteria may infect humans and animals and the infections they cause are harder to treat than those caused by non-resistant bacteria. [2] Antibiotic resistance leads to higher medical costs, prolonged hospital stays, and increased mortality. SCOPE OF THE PROBLEM: Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to teat common infectious diseases. In countries without standard treatment guidelines, antibiotics are often over prescribed by health workers and veterinarians and over used by the public Without urgent action, we are heading for a post antibiotic era, in which common infections and minor injuries can once again kill. [3] International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 17

RESISTANT BACTERIAS: S.aureus is an important bacteria which leads to cause of several hospital infections and also leads to antimicrobial resistance. MRSA-Methicillin Resistant Staphylococcus Aureus, VRSA-Vancomycin Resistant Staphylococcus Aureus, These are resistant forms of staphylococcus aureus. Primary antibiotic resistance bacterial strain. These are experimented with Baicaelin and Oxacillin. To check the virulence of antimicrobial activity. [4] Some bacteria which lead to ampicillin resistance eg.e.coli Some of them are lead to Gram Negative infections. Methicillin-resistant Staphylococcus aureus (MRSA) strains cause serious nosocomial infections all over the world. Overall, approximately 20% of S. aureus isolates in Europe are reported as methicillin resistant, whereas in US hospitals the prevalence ranges from 33% to 55%. [5] The past few years have also witnessed an increase in life-threatening community-acquired infections caused by Panton Valentine leukocidin-producing MRSA in the USA. [5] Increasing use of glycopeptides for treatment of community acquired MRSA infections may result in higher rates of glycopeptide resistance. Since 1996, five vancomycin-intermediate S. aureus (VISA; vancomycin MIC = 8 16 mg L) strains have been identified in Europe, Asia and the USA, and vancomycin-resistant S. aureus (VRSA) strains (vancomycin). [5] International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 18

NEWER RESISTANCE EMERGERS: CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE. [6] CEFTAZIDIME RESISTANT KLEBSIELLA PNEUNONIAE. [6] The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. [7] PREVENTION AND CONTROL [1] Only use antibiotics when certified by health professional Never demand antibiotics if your health worker says you don`t need them Always follow your health worker`s advice when using antibiotics. Never share or use leftover antibiotics Prevent infections by regularly washing hands. International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 19

HEALTH PROFESSIONALS [2] Prevent infections by ensuring your hands, instruments and environment are clean Only prescribe and dispense antibiotics when they are needed, according to current guidelines Report antibiotic resistant infections to surveillance teams Talk to your patients about how to take antibiotics correctly, antibiotic resistance and the dangers of misuse Talk to your parents about preventing infections because of their ignorance to AMR. Avoid overuse of antimicrobials, which leads to AMR. HEALH CARE INDUSTRY [1, 4] Invest in research and development of new antibiotics, vaccines, diagnostics sector can improve the feasibility in people Insufficient ability to access new test and approved. Production and excessive supply of products which leads to easy consuming of antimicrobials by patients. AGRICULTURE SECTOR [1, 3] Only give antibiotics to animals under veterinary supervision Not use antibiotics for growth promotion or to prevent diseases in healthy animals. Vaccinate animals to reduce the need for antibiotics and use alternatives to antibiotics when available International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 20

Promote and apply good practices at all steps of production and processing of foods from animal and plant sources Improve biosecurity on farms and prevent infections through improved hygiene and animal welfare RECENT DEVELOPMENTS [1] While there are some new antibiotics in development, none of them are expected to be effective against the most dangerous forms of antibiotics resistant bacteria Given the ease and frequently with which people now travel, antibiotic resistance efforts from all nations and many sectors IMPACT [1] When infections can no longer be treated by first line antibiotics, more expensive medicines must be used. A longer duration of illness and treatment often in hospitals, increases health care costs as well as the economic burden on family and societies Antibiotic resistance putting the achievements of modern medicine at risk, Organ transplantations, chemotherapy and surgeries such as caesarean section become much more dangerous without effective antibiotics for the prevention and treatment infections. WHO RESPONSE: [1] Tackling antibiotic resistance is a high priority for WHO.A global action on antimicrobial resistance was endorsed at the World Health Assembly in May 2015. The global action plan aims to ensure prevention and treatment of infectious diseases with safe and effective medicines. [1] International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 21

It implies 5 strategic objectives: 1] To improve awareness and understanding of antimicrobial resistance 2] To strengthen surveillance and research 3] To reduce the incidence of infection 4] To optimize the use of antimicrobial medicines 5] To ensure sustainable investment in countering antimicrobial resistance. WORLD ANTIBIOTIC AWARENESS WEEK Held every November since 2015 with the theme `Antibiotics Handle with care` `the global multi-year campaign has increasing volume of activities during the week of the campaign THE GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLIANCE SYSTEM {GLASS} [8] The WHO supported system supports a standardized approach to the collection analysis and sharing of data related to antimicrobial resistance at a global level to inform decision making,drive local, national and regional action. The objectives of GLASS are to: Foster national AMR surveillance systems using harmonized global surveillance standards Assess and report on selected indicators of AMR Detect emerging resistance Inform and assess impact of interventions. International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 22

WHO seeks the collaboration with WHO collaborating centers, existing surveillance networks, partner technical institutions to support countries for GLASS implementation. GLOBAL ANTIBIOTIC RESEARCH AND DEVELOPMENT PARTNERSHIP {GARDP} A joint initiative of WHO and drugs for Neglected Diseases initiative (DNDi), GARDP encourages research and development through public-private partnership. By 2023, the partnership aims to develop and deliver up to four new treatments, of existing antibiotics and acceleration of the entry of new antibiotic drugs. INTEGRACY COORDINATION GROUP ON ANTIMICROBIAL RESISTANCE (IACG) [1,9] The United Nations Secretary-General has established IACG to improve coordination between international organizations and to ensure effective global action against this threat to health security. The IACG is co-chaired by the UN Deputy Secretary General and the Director General of WHO and comprises high level representatives of relevant UN agencies, other international organizations and individual experts across different sectors. CONCLUSION: Here by concluding, the ignorance is the global negativeness that lead to a great medical danger. Thus, Doctors, Health care persons, Social interested people make awareness to the anti-microbial resistance to the common people that leads to extend the longevity of life. International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 23

REFERENCES: 1. Who Library Cataloguing-In-Publication Data Antibiotic Resistance: Multi-Country Public Awareness Survey I. World Health Organization. Isbn 978 92 4 150981 7 Subject Headings Are Available From Who Institutional Repository 2. Tillotson G (2016) The Fight Against Bacterial Resistance - New Initiatives But Much Still Needed- J Infect Dis Ther Volume 4: Issue 5 E109. 3. Rabindran, Viswanathan D and Devarajan V- Emerging Antibiotic Resistance of Blood Stream Infections among Children- J Infect Dis Ther -3:247.ISSN:2332-0877 4. Young-Soo Lee, Eun-Kyung Jung and Jeong-Dan Cha - Synergistic Effect Between Baicalein and Antibiotics against Clinic Methicillin and Vancomycin-Resistant Staphylococcus Aureus. - (Chemo Open Access 2015, 4:1 5. P.C. Appelbaum- MRSA the Tip Of The Iceberg. Clin Microbial Infect.2006 April; 12 suppl 2:3-10 6. Arwa Alumran, Xiang-Yu Hou, Jiandong Sun, Abdullah Yousef And Cameron Hurst- The Parental Use Of Antibiotics In Children In Saudi Arabia (Epidemiology (Sunnyvale) 5:194. 7. Neu Hc (1992) - The Crisis in Antibiotic Resistance. Science -257: 1064-1073. 8. Priyavadhana,P.. "The Role of Antibiotics in Treatment of Chronic Periodontitis." International Journal of Dental Sciences and Research 2.1 (2014): 16-18. 9. Global Antimicrobial Resistance Surveillance System (Glass) Http://Apps.Who.Int/Iris/Bitstream/10665/204117/1/Who_Ohe_Ped_Amr_2016.1_Eng.P df. International Journal of Innovations in Dental Sciences / January 2018 / Vol 3 / Issue 1 24